Skip to Main Content

Author Details

Robert S Parker
University of Pittsburgh
1999
37
14
PMIDPaper TitleJournal TitlePublished Year
36655223Nasal epithelial cell culture fluorescence recovery after photobleaching predicts cystic fibrosis therapeutic response.ERJ Open Res2022
35665340Identification of Clinical Phenotypes in Septic Patients Presenting With Hypotension or Elevated Lactate.Front Med (Lausanne)2022
33305364Improvements and limitations in developing multivariate models of hemorrhage and transfusion risk for the obstetric population.Transfusion2021
32032282Accelerating availability of clinically-relevant parameter estimates from thromboelastogram point-of-care device.J Trauma Acute Care Surg2020
31494805A physiologically-motivated model of cystic fibrosis liquid and solute transport dynamics across primary human nasal epithelia.J Pharmacokinet Pharmacodyn2019
31427833APT-MCMC, a C++/Python implementation of Markov Chain Monte Carlo for parameter identification.Comput Chem Eng2018
33598665Coupled Model of Blood Volume and Activated Clotting Factor Concentration during Childbirth.IFAC Pap OnLine2018
31384843Characterization of Blood Volume Space and Mitochondrial Activity in Functional Renal Cells.IFAC Pap OnLine2018
28904202Discrete Dynamical Modeling of Influenza Virus Infection Suggests Age-Dependent Differences in Immunity.J Virol2017
26968022A One-Nearest-Neighbor Approach to Identify the Original Time of Infection Using Censored Baboon Sepsis Data.Crit Care Med2016
33134139Modeling and Hemofiltration Treatment of Acute Inflammation.Processes (Basel)2016
27009167Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung.Eur Respir J2016
26003043A systems approach to modeling drug release from polymer microspheres to accelerate in vitro to in vivo translation.J Control Release2015
24743971Quantitative imaging of airway liquid absorption in cystic fibrosis.Eur Respir J2014
25383714A physiologically-motivated compartment-based model of the effect of inhaled hypertonic saline on mucociliary clearance and liquid transport in cystic fibrosis.PLoS One2014
24992991Modulation of chemokine gradients by apheresis redirects leukocyte trafficking to different compartments during sepsis, studies in a rat model.Crit Care2014
22969415Correction: ensemble models of neutrophil trafficking in severe sepsis.PLoS Comput Biol2012
21261400Pharmacokineticâ¿¿pharmacodynamic modelling of intracellular gemcitabine triphosphate accumulation: translating in vitro to in vivo.IET Syst Biol2011
21962329Modeling competitive cytokine adsorption dynamics within hemoadsorption beads used to treat sepsis.J Chromatogr A2011
21364543A potential role of distinctively delayed blood clearance of recombinant adeno-associated virus serotype 9 in robust cardiac transduction.Mol Ther2011
20147315Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges.J R Soc Interface2010
18008070Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice.Cancer Chemother Pharmacol2008
19356671Pharmacokinetic modeling of motexafin gadolinium disposition in mouse tissues using optical pharmacokinetic system measurements.Photodiagnosis Photodyn Ther2008
18550083An ensemble of models of the acute inflammatory response to bacterial lipopolysaccharide in rats: results from parameter space reduction.J Theor Biol2008
18222419Nonlinear model predictive control for dosing daily anticancer agents using a novel saturating-rate cell-cycle model.Comput Biol Med2008
17604637Noninvasive and nondestructive optical spectroscopic measurement of motexafin gadolinium in mouse tissues: comparison to high-performance liquid chromatography.J Photochem Photobiol B2007
19885088Dynamic modeling of exercise effects on plasma glucose and insulin levels.J Diabetes Sci Technol2007
17020990A mass balance and disposition study of the DNA methyltransferase inhibitor zebularine (NSC 309132) and three of its metabolites in mice.Clin Cancer Res2006
17946396Mixed meal modeling and disturbance rejection in type I diabetic patients.Conf Proc IEEE Eng Med Biol Soc2006
17109593Dynamic modeling of free fatty acid, glucose, and insulin: an extended "minimal model".Diabetes Technol Ther2006
16316162In vivo fluorescence detection of glucose using a single-walled carbon nanotube optical sensor: design, fluorophore properties, advantages, and disadvantages.Anal Chem2005
16986259Accounting for quiescent cells in tumour growth and cancer treatment.Syst Biol (Stevenage)2005
16205839Control-relevant modeling of the antitumor effects of 9-nitrocamptothecin in SCID mice bearing HT29 human colon xenografts.J Pharmacokinet Pharmacodyn2005
14580575Bioreactor state estimation and control.Curr Opin Biotechnol2003
11211662The intravenous route to blood glucose control.IEEE Eng Med Biol Mag2001
11369083Control-relevant modeling in drug delivery.Adv Drug Deliv Rev2001
9932336A model-based algorithm for blood glucose control in type I diabetic patients.IEEE Trans Biomed Eng1999
  • 1 - 37 of 37

Recommended Authors

Mayo Clinic
Career Start Year 2012
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2009
Number of shared co-authors 1
Rice University
Career Start Year 2007
Number of shared co-authors 3
University of Pittsburgh
Career Start Year 2007
Number of shared co-authors 14
Virginia Commonwealth University
Career Start Year 2006
Number of shared co-authors 4
Center for Critical Care Computational Intelligence, Vrije Universiteit
Career Start Year 2006
Number of shared co-authors 1
Unit for Pharmacokinetics and Drug Metabolism, University of Gothenburg
Career Start Year 2005
Number of shared co-authors 0
Linkoping University
Career Start Year 2005
Number of shared co-authors 1
Vantage Research Inc.
Career Start Year 2004
Number of shared co-authors 4
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 0
Roche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd.
Career Start Year 2002
Number of shared co-authors 0
Christchurch Hospital
Career Start Year 2001
Number of shared co-authors 0
University Hospital Bonn
Career Start Year 2000
Number of shared co-authors 4
Merck & Co.
Career Start Year 2000
Number of shared co-authors 0
University of Vermont
Career Start Year 1999
Number of shared co-authors 5
Vanderbilt University Medical Center
Career Start Year 1999
Number of shared co-authors 0
University of Kansas Medical Center
Career Start Year 1998
Number of shared co-authors 5
Geisel School of Medicine at Dartmouth, Norris Cotton Cancer Center
Career Start Year 1997
Number of shared co-authors 0
University of Pennsylvania Perelman School of Medicine
Career Start Year 1995
Number of shared co-authors 0
Institut fur Experimentelle und Angewandte Physik, University of Regensburg
Career Start Year 1994
Number of shared co-authors 0
Health Services and Systems Research, Duke-NUS Medical School
Career Start Year 1990
Number of shared co-authors 0
Vanderbilt University
Career Start Year 1986
Number of shared co-authors 2
Institute for Advanced Study, University of Amsterdam.
Career Start Year 1986
Number of shared co-authors 0
University of Southern California Keck School of Medicine
Career Start Year 1985
Number of shared co-authors 2
Department of Pharmacy, Uppsala University
Career Start Year 1983
Number of shared co-authors 0
Tufts Clinical and Translational Science Institute, 7Tufts Medical Center
Career Start Year 1983
Number of shared co-authors 0
Cincinnati Children's Hospital Medical Center
Career Start Year 1982
Number of shared co-authors 0
Massachusetts Institute of Technology
Career Start Year 1979
Number of shared co-authors 0
Division of Pharmaceutics and Translational Therapeutics, University of Iowa
Career Start Year 1975
Number of shared co-authors 0
University of California san francisco
Career Start Year 1973
Number of shared co-authors 2

Collaborators

University of Pittsburgh
Co-authored papers 13
University of Pittsburgh
Co-authored papers 5
Department of Pharmacological and Pharmaceutical Sciences, University of Houston
Co-authored papers 5
University of Pittsburgh
Co-authored papers 4
University of Pittsburgh
Co-authored papers 3
Spectral Medical Inc.
Co-authored papers 3
Co-authored papers 3
McGowan Institute for Regenerative Medicine, University of Pittsburgh
Co-authored papers 3
University of Pittsburgh
Co-authored papers 3
Zhongnan Hospital of Wuhan University
Co-authored papers 2
Center for the Neural Basis of Cognition
Co-authored papers 2
University of Pittsburgh
Co-authored papers 2
University of Pittsburgh Medical Center
Co-authored papers 2
University of Pittsburgh Medical Center
Co-authored papers 2
University of Pittsburgh
Co-authored papers 2
Institute of Neuroscience and Medicine (INM-3)
Co-authored papers 2
University of Pittsburgh School of Medicine
Co-authored papers 2
Chinese People's Liberation Army (PLA) General Hospital
Co-authored papers 1
Edouard Herriot Hospital
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Carlow University
Co-authored papers 1
Magee-Womens Research Institute, University of Pittsburgh School of Medicine
Co-authored papers 1
UPMC Children's Hospital of Pittsburgh
Co-authored papers 1
Oregon Health and Science University
Co-authored papers 1
University of Pittsburgh Medical Center
Co-authored papers 1
Co-authored papers 1
Indiana University School of Medicine
Co-authored papers 1
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology
Co-authored papers 1
The Clinical Research, University of Pittsburgh School of Medicine
Co-authored papers 1
University of Pittsburgh
Co-authored papers 1